Publicaciones en las que colabora con Ignacio Marcos Larráyoz Roldán (13)

2018

  1. Adrenomedullin, a Novel Target for Neurodegenerative Diseases

    Molecular Neurobiology, Vol. 55, Núm. 12, pp. 8799-8814

  2. Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer’s Disease

    Molecular Neurobiology, Vol. 55, Núm. 6, pp. 5177-5183

  3. Reduced Adrenomedullin Parallels Microtubule Dismantlement in Frontotemporal Lobar Degeneration

    Molecular Neurobiology, Vol. 55, Núm. 12, pp. 9328-9333

2017

  1. Adrenomedullin contributes to age-related memory loss in mice and is elevated in aging human brains

    Frontiers in Molecular Neuroscience, Vol. 10

2008

  1. Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells

    Biochemical Pharmacology, Vol. 75, Núm. 3, pp. 639-648

2006

  1. Characterization of the rat Na+/nucleoside cotransporter 2 and transport of nucleoside-derived drugs using electrophysiological methods

    American Journal of Physiology - Cell Physiology, Vol. 291, Núm. 6

2005

  1. Cell entry and export of nucleoside analogues

    Virus Research, Vol. 107, Núm. 2, pp. 151-164

2004

  1. Electrophysiological Characterization of the Human Na +/Nucleoside Cotransporter 1 (hCNT1) and Role of Adenosine on hCNT1 Function

    Journal of Biological Chemistry, Vol. 279, Núm. 10, pp. 8999-9007

  2. Erratum: Electrophysiological characterization of the human Na +/nucleoside cotransporter 1 (hCNT1) and role of adenosine on hCNT1 function (The Journal of Biological Chemistry (2004) 279 (8999-9007))

    Journal of Biological Chemistry

  3. Interaction of nucleoside inhibitors of HIV-1 reverse transcriptase with the concentrative nucleoside transporter-1 (SLC28A1)

    Antiviral Therapy, Vol. 9, Núm. 6, pp. 993-1002

2002

  1. Nucleoside transporters in absorptive epithelia

    Journal of Physiology and Biochemistry

2001

  1. Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5[prime]-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug

    Molecular Pharmacology, Vol. 59, Núm. 6, pp. 1542-1548

2000

  1. Electrogenic uptake of nucleosides and nucleoside-derived drugs by the human nucleoside transporter 1 (hCNT1) expressed in Xenopus laevis oocytes

    FEBS Letters, Vol. 481, Núm. 2, pp. 137-140